Skip to main content
Integrity IndexIntegrity Index
← Companies
RGEN

REPLIGEN CORP

Data as of Oct 13, 2026
RGEN
CIK 730272HEALTHCAREBiological Products, (No Diagnostic Substances)
Federal contracts since 2024
$378K
3 awards · latest Sep 3, 2026

Trades

8 reported trades in RGEN by 3 members of Congress since Jan 20, 2022: 3 purchases and 5 sales. Amounts are the ranges members report on periodic transaction reports.

Trades
8
Buys / sells
3 / 5
Members
3

Most recent

  • RLisa McclainSale$1,001+Oct 31, 2025
  • RLisa McclainPurchase$1,001+Oct 30, 2025
  • RLisa McclainSale$1,001+Oct 30, 2025
  • RLisa McclainPurchase$1,001+Jul 22, 2025
  • RLisa McclainSale$1,001+Jun 17, 2025
  • RLisa McclainPurchase$1,001+Jun 11, 2025
  • RJefferson ShreveSale$15,001+Apr 7, 2025
  • DRo KhannaSale$1,001+Jan 20, 2022

Data: FEC (PAC contributions, Schedule A), Quiver Quantitative (congressional holdings, lobbying, contracts), Senate Lobbying Disclosure Act filings, USAspending, congressional periodic transaction reports. Records are matched to REPLIGEN CORP through its SEC registration (CIK 730272) and tickers RGEN.

As of: contract actions through Sep 3, 2026. Snapshot rebuilt Oct 13, 2026.

Holdings values are estimates from disclosed ranges. PAC contributions cover the current and previous election cycle and count only gifts to sitting members' principal campaign committees, so leadership PACs and losing candidates are not included.